Armata Pharmaceuticals

Armata Pharmaceuticals is a clinical-stage biotechnology company focused on developing precision-targeted phage therapies for the treatment of drug-resistant bacterial infections to improve human health, addressing multidrug-resistant bacterial infections and preventable microbiome-related infectious diseases. To tackle the rapidly growing global issue of multidrug-resistant bacterial infections, Armata is leveraging two proprietary platforms — synthetic phage and peptides.